Polycystic ovary syndrome

47,792views

test

00:00 / 00:00

Polycystic ovary syndrome

MDY2U2 - GI/OB

MDY2U2 - GI/OB

Herpes simplex virus
Candida
Aphthous ulcers
Lichen planus
Oral cancer
Anatomy of the oral cavity
Oral candidiasis
Blood and nerve supply of the oral cavity
Anatomy and physiology of the teeth
Development of the teeth
Cleidocranial dysplasia
Bruxism
Dental abscess
Gingivitis and periodontitis
Dental caries disease
Tooth decay and cavities
Eruption of primary and permanent dentitions
Ludwig angina
Taste and the tongue
Sialadenitis
Anatomy of the salivary glands
Sjogren syndrome: Clinical
Sjogren syndrome: Pathology review
Chewing and swallowing
Gastroesophageal reflux disease (GERD)
Gastroesophageal reflux disease (GERD): Clinical
Scleroderma
Pyloric stenosis
Pediatric vomiting: Clinical
Meckel diverticulum
Gastric motility
Esophageal motility
Enteric nervous system
Intussusception
Volvulus
Hirschsprung disease
Gastric cancer
Stomach histology
Barrett esophagus
Esophageal disorders: Clinical
Plummer-Vinson syndrome
Eosinophilic esophagitis (NORD)
Achalasia
Diffuse esophageal spasm
Gastritis
Diarrhea: Clinical
Clostridium difficile (Pseudomembranous colitis)
Inflammatory bowel disease: Clinical
Hernias: Clinical
Abdominal hernias
Appendicitis: Clinical
Appendicitis
Colorectal polyps and cancer: Pathology review
Colorectal polyps
Colorectal cancer
Gallstones
Gallbladder disorders: Pathology review
Acute pancreatitis
Jaundice: Clinical
Celiac disease
Hepatitis
Non-alcoholic fatty liver disease
Alcohol-induced liver disease
Anemia of chronic disease
Wilson disease
Cirrhosis
Hemochromatosis
Portal hypertension
Pharmacokinetics: Drug metabolism
Acetaminophen (Paracetamol)
Primary biliary cirrhosis
Primary sclerosing cholangitis
Hepatocellular carcinoma
Hypertriglyceridemia
Familial hypercholesterolemia
Atherosclerosis and arteriosclerosis: Pathology review
Hunger and satiety
Hypercholesterolemia: Clinical
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes mellitus: Clinical
Insulin
Thyroid nodules and thyroid cancer: Clinical
Hypothyroidism
Hypothyroidism and thyroiditis: Clinical
Hyperthyroidism: Clinical
Hyperthyroidism
Hashimoto thyroiditis
Riedel thyroiditis
Thyroid storm
Hypothyroidism medications
Hyperthyroidism medications
Constitutional growth delay
Growth hormone deficiency
Amenorrhea
Puberty and Tanner staging
Premature ovarian failure
Polycystic ovary syndrome
Pituitary adenomas and pituitary hyperfunction: Clinical
Menopause
Anatomy and physiology of the female reproductive system
Menstrual cycle
Oxytocin and prolactin
Thyroid hormones
Pregnancy
Fetal circulation
Fetal alcohol syndrome
Preeclampsia & eclampsia
Endometritis
Abnormal uterine bleeding: Clinical
Vulvovaginitis: Clinical
Routine prenatal care: Clinical
Stages of labor
Vitamin D
Osteomalacia and rickets
Parathyroid conditions and calcium imbalance: Clinical
Hyperparathyroidism
Parathyroid hormone
Hypoparathyroidism
Hypocalcemia
Calcitonin
Osteoporosis
Bone remodeling and repair
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Human papillomavirus
Cervical cancer
Cervical cancer: Clinical
Cervical cancer: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review

Assessments

Flashcards

0 / 13 complete

USMLE® Step 1 questions

0 / 2 complete

High Yield Notes

9 pages

Flashcards

Polycystic ovary syndrome

0 of 13 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 2 complete

A 30-year-old woman presents to the clinic to establish care. She is starting a new job as a receptionist and wants to "take care of her irregular periods.” Her menarche was at age 14 and she has been having irregular periods since then. Review of systems is significant for deepening of voice. Past medical history is unremarkable. She only takes over the counter multivitamins. Vitals are within normal limits. BMI is 32 kg/m2. Physical examination shows papulo-pustular acne on the face and a receding hairline. Pelvic examination reveals normal external genitalia and a mobile and nontender uterus with no adnexal masses. This patient is at increased risk of developing which of the following?  

External References

First Aid

2024

2023

2022

2021

Polycystic ovarian syndrome (PCOS)

anovulation p. 663

antiandrogens p. 675

clomiphene p. 674

endometrial hyperplasia p. 658

ovarian neoplasm risk p. 664

Transcript

Watch video only

In polycystic ovary syndrome, “poly” means many, and “cystic” refers to cysts.

So you might think that having many ovarian cysts is a crucial part of polycystic ovary syndrome.

But while some people with polycystic ovarian syndrome do have ovarian cysts, ovarian cysts are no longer a necessary characteristic of the condition.

Instead, polycystic ovary syndrome is a dysfunction in the hypothalamic-pituitary-ovarian axis, which are the hormones that regulate the menstrual cycle.

A normal menstrual cycle can be divided into two phases: the follicular phase, which takes place before ovulation, and the luteal phase, which takes place after ovulation.

During the follicular phase, the hypothalamus secretes gonadotropin-releasing hormone, or GnRH.

GnRH makes the anterior pituitary gland secrete two other hormones, called gonadotropins, in roughly equal amounts, which it releases in pulses.

One of these gonadotropins is the luteinizing hormone, or LH.

The other is the follicle-stimulating hormone, or FSH.

LH and FSH travel to the follicles in the ovaries.

The follicles are small clusters of theca and granulosa cells that protect the developing oocyte, or egg.

The theca cells develop LH receptors which allow them to bind LH, and in response they secrete a hormone called androstenedione.

Granulosa cells develop FSH receptors, which allow them to bind to FSH and produce an enzyme called aromatase, which converts the androstenedione into 17β-estradiol - a member of the estrogen family.

As follicles grow, the level of 17β-estradiol in the blood increases, and it acts as a negative feedback signal – that is, it tells the pituitary to secrete less FSH.

Less FSH in the blood means there’s only enough to stimulate one follicle.

The follicle that has the most FSH receptors grows the quickest, and becomes the dominant follicle.

At this point, about midway through the follicular phase, the granulosa cells also begin to develop LH receptors.

As that happens, the dominant follicle keeps secreting estrogen, and the rising estrogen levels make the pituitary more sensitive to the pulsatile action of GnRH from the hypothalamus.

Blood estrogen levels start to climb, and now the estrogen from the dominant follicle becomes a positive feedback signal – that is, it makes the pituitary secrete a whole lot of FSH and LH in response to GnRH.

This happens a day or two before ovulation, and the massive surge of FSH and LH binds to the granulosa and theca cells which help facilitate rupture of the ovarian follicle and release of the oocyte.

While the rest theca and granulosa cells degenerate and die off, a now fully-matured oocyte breaks away from the dominant follicle, and pops out of the ovary.

The egg begins its journey down the fallopian tube to the uterus. The luteal phase has begun.

While polycystic ovary syndrome affects the whole menstrual cycle, it really starts with a breakdown in this follicular phase.

In polycystic ovarian syndrome, the anterior pituitary makes too much LH, at least double the amount as FSH.

Excessive LH causes the theca cells to produce excess amounts of androstenedione, way too much for those granulosa cells to convert.

Summary

Polycystic ovary syndrome or just PCOS, refers to a set of symptoms due to excessive androgen production in women. Signs and symptoms of PCOS include irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, trouble getting pregnant, and patches of thick, darker, velvety skin. Associated conditions include type 2 diabetes, obesity, obstructive sleep apnea, heart disease, mood disorders, and endometrial cancer. Management for PCOS may involve lifestyle modifications such as diet and exercise, hormone therapy, and medications.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 7/E (ENHANCED EBOOK)" McGraw Hill Professional (2014)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Genetic, hormonal and metabolic aspects of PCOS: an update" Reproductive Biology and Endocrinology (2016)
  7. "Androgens in Polycystic Ovary Syndrome: The Role of Exercise and Diet" Seminars in Reproductive Medicine (2009)